Hosted on MSN8mon
FDA Approves Novel Nebulized Therapy for COPD
The FDA approved inhaled ensifentrine (Ohtuvayre) as maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults, drugmaker Verona Pharma announced on Wednesday. A first-in ...
OHTUVAYRETM (Ensifentrine) Now Available Through Promptcare
Specialty pharmacy expands access to an innovative, steroid-free treatment NEW PROVIDENCE, NJ, UNITED STATES, March 3, 2025 /EINPresswire / -- ...